How does Dapagliflozin work? Understanding SGLT2 inhibitors. Published 2019-01-30 Download video MP4 360p Recommendations 08:15 SGLT2 Inhibitors and Heart Failure 07:19 Gout: Visual Explanation for Students 13:16 Dapagliflozin - Mechanism, side effects, precautions & uses 06:08 How do Thiazide Diuretics Work? Understanding Bendroflumethiazide and Indapamide 16:24 How SGLT2 Inhibitors Protect The Kidney 07:55 Understanding The Dexamethasone Suppression Test 02:44 SGLT2 Inhibitors Explained in 3 Minutes 06:33 Role of GLP-1 Receptor Agonists for Weight Loss 35:24 Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?' 08:07 Understanding Osteoarthritis 10:30 Understanding Hepatitis B Serology Results 32:28 Diabetes Drugs (Oral Antihyperglycemics & Insulins) 10:20 DPP-4 Inhibitors | Dr. Shantanu R. Joshi | 2019 07:43 Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists 08:28 What causes Cushings Syndrome? 06:34 Understanding Pacemakers 05:26 Understanding Cellulitis: Skin and Soft Tissue Infections 06:37 Understanding Pleural Effusions 10:44 Myasthenia Gravis 11:25 Understanding Jugular Venous Pressure (JVP) Similar videos 01:44 SGLT2 Inhibitors Mechanism of Action 03:23 What are SGLT2 inhibitors - Chronic Kidney Disease | UHL NHS Trust 09:06 SGLT2 Inhibitors in Chronic Kidney Disease 03:21 How does SGLT2 Inhibition Improve Heart Failure? 02:34 SGLT2 Inhibitors (Dapagliflozin, empagliflozin) | Type 2 Diabetes revision video 10:57 Best Practices for Starting SGLT2 Inhibitors in HFpEF Treatment 01:10 SGLT2 inhibitors | Canagliflozin Dapagliflozin Empagliflozin | Mechanism of action 11:01 Why SGLT2 Inhibitors Cause Euglycemic DKA 05:31 SGLT-2 Inhibitors - Dapagliflozin, Empagliflozin, Canagliflozin & Ertugliflozin 03:35 SGLT-2 Inhibitors, Explained: How They Work, Their Benefits and Risks 13:07 Nurse Webinars - SGLT2i - Dapagliflozin and Empagliflozin 03:49 SGLT2 inhibitors (dapagliflozin, canagliflozin, empagliflozin) for diabetes: mechanism, side effects 06:11 DAPA-CKD: Does confirmed renoprotection make the case for first-line SGLT2 inhibition? | Luigi Gnudi More results